Are you Dr. Hortobagyi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 101 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Summary
- Dr. Gabriel Hortobagyi, MD is an oncologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Florida, and Ohio. He is affiliated with University of Texas M.D. Anderson Cancer Center and is a Professor of Medicine at University Tex Houston.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1974 - 1976
Columbia Saint Luke's Medical CenterResidency, Internal Medicine, 1971 - 1974
National University of ColombiaClass of 1970
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 1975 - 2024
OH State Medical License 1974 - 2018
PA State Medical License 1973 - 1978- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer Start of enrollment: 2005 Sep 01
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) Start of enrollment: 2013 Dec 17
Publications & Presentations
PubMed
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique.Emily J Gallagher, Heather Moore, Mario E Lacouture, Susan F Dent, Azeez Farooki, Marcus D Goncalves, Claudine Isaacs, Abigail Johnston, Dejan Juric, Zoe Quandt, Laura...> ;NPJ Breast Cancer. 2024 Jan 31
- 1 citationsVitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221.Ciao-Sin Chen, Gary Zirpoli, William E Barlow, G Thomas Budd, Bryan McKiver, Lajos Pusztai, Gabriel N Hortobagyi, Kathy S Albain, M Imad Damaj, Andrew K Godwin, Alasta...> ;Journal of the National Comprehensive Cancer Network. 2023 Nov 1
- Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research.Fabio Conforti, Laura Pala, Tommaso De Pas, Emma Zattarin, Chiara Catania, Emilia Cocorocchio, Giovanna Rossi, Daniele Laszlo, Marco Colleoni, Alberto Zambelli, Gabrie...> ;Clinical Cancer Research. 2024 Mar 15
- Join now to see all
Press Mentions
World Cancer Day 2023: All You Need to KnowFebruary 4th, 2023- 22 Research Highlights from the Past YearDecember 19th, 2022
- Novartis : NEJM Publication of Novartis Kisqali® Data Shows Longest Median Overall Survival Ever Reported in HR+/HER2- Advanced Breast CancerMarch 14th, 2022
- Join now to see all
Grant Support
- Developmental Reseach ProgramNational Cancer Institute2008–2009
- Career Development ProgramNational Cancer Institute2008–2009
- Administrative CoreNational Cancer Institute2008–2009
- Utmdacc Spore In Breast CancerNational Cancer Institute2005–2009
- Specialized Program Of Research Excellence/Breast CancerNational Cancer Institute1992–1994
Professional Memberships
- Fellow
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
